Assessing the Rate of Serious Infections in Rheumatoid Arthritis (RA) Patients who Receive Other Biologic Therapies after Discontinuing Rituximab (RTX)
Author(s):
Genovese, M.; Cividino, A.; Keystone, E.; Breedveld, F.; Emery, P.; Cohen, S.; Matteson, E.; Burke, L.; Chai, A.; Reiss, W.; Sweetser, M.; Shaw, T.
